Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Gross Profit: 2017-2024

Historic Gross Profit for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to $258.0 million.

  • Arcus Biosciences' Gross Profit fell 45.83% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.0 million, marking a year-over-year decrease of 8.75%. This contributed to the annual value of $258.0 million for FY2024, which is 120.51% up from last year.
  • As of FY2024, Arcus Biosciences' Gross Profit stood at $258.0 million, which was up 120.51% from $117.0 million recorded in FY2023.
  • Arcus Biosciences' Gross Profit's 5-year high stood at $383.0 million during FY2021, with a 5-year trough of $78.0 million in FY2020.
  • Moreover, its 3-year median value for Gross Profit was $117.0 million (2023), whereas its average is $162.3 million.
  • Per our database at Business Quant, Arcus Biosciences' Gross Profit skyrocketed by 420.00% in 2020 and then tumbled by 70.76% in 2022.
  • Yearly analysis of 5 years shows Arcus Biosciences' Gross Profit stood at $78.0 million in 2020, then soared by 391.03% to $383.0 million in 2021, then slumped by 70.76% to $112.0 million in 2022, then grew by 4.46% to $117.0 million in 2023, then surged by 120.51% to $258.0 million in 2024.